Leerink Partnrs Issues Positive Estimate for BEAM Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Leerink Partnrs lifted their Q1 2025 earnings estimates for shares of Beam Therapeutics in a research note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($1.20) for the quarter, […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Leerink Partnrs lifted their Q1 2025 earnings estimates for shares of Beam Therapeutics in a research note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($1.20) for the quarter, […]
